<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37339001</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>SRF deletion results in earlier disease onset in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e167694</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.167694</ELocationID><Abstract><AbstractText>Changes in neuronal activity modulate the vulnerability of motoneurons (MNs) in neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). So far, the molecular basis of neuronal activity's impact in ALS is poorly understood. Herein, we investigated the impact of deleting the neuronal activity-stimulated transcription factor (TF) serum response factor (SRF) in MNs of SOD1G93A mice. SRF was present in vulnerable MMP9+ MNs. Ablation of SRF in MNs induced an earlier disease onset starting around 7-8 weeks after birth, as revealed by enhanced weight loss and decreased motor ability. This earlier disease onset in SRF-depleted MNs was accompanied by a mild elevation of neuroinflammation and neuromuscular synapse degeneration, whereas overall MN numbers and mortality were unaffected. In SRF-deficient mice, MNs showed impaired induction of autophagy-encoding genes, suggesting a potentially new SRF function in transcriptional regulation of autophagy. Complementary, constitutively active SRF-VP16 enhanced autophagy-encoding gene transcription and autophagy progression in cells. Furthermore, SRF-VP16 decreased ALS-associated aggregate induction. Chemogenetic modulation of neuronal activity uncovered SRF as having important TF-mediating activity-dependent effects, which might be beneficial to reduce ALS disease burden. Thus, our data identify SRF as a gene regulator connecting neuronal activity with the cellular autophagy program initiated in degenerating MNs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jialei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Neurobiochemistry and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikwella</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Neurobiochemistry and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinske</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Neurobiochemistry and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roselli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases-Ulm (DZNE-Ulm), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kn&#xf6;ll</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Neurobiochemistry and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>6PLQ3CP4P3</RegistryNumber><NameOfSubstance UI="D005047">Etoposide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026362">Serum Response Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000632244">Srf protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005047" MajorTopicYN="N">Etoposide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026362" MajorTopicYN="N">Serum Response Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Autophagy</Keyword><Keyword MajorTopicYN="N">Mouse models</Keyword><Keyword MajorTopicYN="N">Neuroscience</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>12</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37339001</ArticleId><ArticleId IdType="pmc">PMC10445689</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.167694</ArticleId><ArticleId IdType="pii">167694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pun S, et al. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9(3):408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81(2):333&#x2013;348. doi: 10.1016/j.neuron.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy F, et al. Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis. Elife. 2014;3:e04046. doi: 10.7554/eLife.04046.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.04046</ArticleId><ArticleId IdType="pmc">PMC4227046</ArticleId><ArticleId IdType="pubmed">25313866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel M, Zytnicki D. Molecular and electrophysiological properties of mouse motoneuron and motor unit subtypes. Curr Opin Physiol. 2019;8:23&#x2013;29. doi: 10.1016/j.cophys.2018.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cophys.2018.11.008</ArticleId><ArticleId IdType="pmc">PMC7302113</ArticleId><ArticleId IdType="pubmed">32551406</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, et al. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12(5):627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JA, et al. Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons. Nat Neurosci. 2021;24(4):572&#x2013;583. doi: 10.1038/s41593-020-00795-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00795-0</ArticleId><ArticleId IdType="pmc">PMC8016743</ArticleId><ArticleId IdType="pubmed">33589834</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli F, Caroni P. From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases. Neuron. 2015;85(5):901&#x2013;910. doi: 10.1016/j.neuron.2014.12.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.063</ArticleId><ArticleId IdType="pubmed">25741719</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, et al. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol. 2005;563(pt 3):843&#x2013;854. doi: 10.1113/jphysiol.2004.074138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2004.074138</ArticleId><ArticleId IdType="pmc">PMC1665614</ArticleId><ArticleId IdType="pubmed">15649979</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zundert B, et al. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci. 2008;28(43):10864&#x2013;10874. doi: 10.1523/JNEUROSCI.1340-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1340-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844745</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId></ArticleIdList></Reference><Reference><Citation>Pambo-Pambo A, et al. Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice. J Neurophysiol. 2009;102(6):3627&#x2013;3642. doi: 10.1152/jn.00482.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00482.2009</ArticleId><ArticleId IdType="pubmed">19828728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, et al. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol Disord Drug Targets. 2010;9(3):297&#x2013;304. doi: 10.2174/187152710791292576.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791292576</ArticleId><ArticleId IdType="pubmed">20406181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Silva MdL, et al. Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife. 2018;7:e30955. doi: 10.7554/eLife.30955.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30955</ArticleId><ArticleId IdType="pmc">PMC5922970</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipchuk A, et al. Early hypoexcitability in a subgroup of spinal motoneurons in superoxide dismutase 1 transgenic mice, a model of amyotrophic lateral sclerosis. Neuroscience. 2021;463:337&#x2013;353. doi: 10.1016/j.neuroscience.2021.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.01.039</ArticleId><ArticleId IdType="pubmed">33556455</ArticleId></ArticleIdList></Reference><Reference><Citation>Delestr&#xe9;e N, et al. Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis. J Physiol. 2014;592(7):1687&#x2013;1703. doi: 10.1113/jphysiol.2013.265843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2013.265843</ArticleId><ArticleId IdType="pmc">PMC3979619</ArticleId><ArticleId IdType="pubmed">24445319</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin A-C, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015;6:5999. doi: 10.1038/ncomms6999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6999</ArticleId><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M, et al. 4-aminopyridine induced activity rescues hypoexcitable motor neurons from amyotrophic lateral sclerosis patient-derived induced pluripotent stem cells. Stem Cells. 2016;34(6):1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80(1):80&#x2013;96. doi: 10.1016/j.neuron.2013.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#x105;czyk M, et al. Synaptic restoration by cAMP/PKA drives activity-dependent neuroprotection to motoneurons in ALS. J Exp Med. 2020;217(8):e20191734. doi: 10.1084/jem.20191734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191734</ArticleId><ArticleId IdType="pmc">PMC7398175</ArticleId><ArticleId IdType="pubmed">32484501</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese A, et al. Synaptic disruption and CREB-regulated transcription are restored by K+ channel blockers in ALS. EMBO Mol Med. 2021;13(7):e13131. doi: 10.15252/emmm.202013131.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013131</ArticleId><ArticleId IdType="pmc">PMC8261490</ArticleId><ArticleId IdType="pubmed">34125498</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap E-L, Greenberg ME. Activity-regulated transcription: bridging the gap between neural activity and behavior. Neuron. 2018;100(2):330&#x2013;348. doi: 10.1016/j.neuron.2018.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.013</ArticleId><ArticleId IdType="pmc">PMC6223657</ArticleId><ArticleId IdType="pubmed">30359600</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz DA, Bloodgood BL. Mechanisms that communicate features of neuronal activity to the genome. Curr Opin Neurobiol. 2020;63:131&#x2013;136. doi: 10.1016/j.conb.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2020.03.002</ArticleId><ArticleId IdType="pubmed">32416470</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoll B, Nordheim A. Functional versatility of transcription factors in the nervous system: the SRF paradigm. Trends Neurosci. 2009;32(8):432&#x2013;442. doi: 10.1016/j.tins.2009.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2009.05.004</ArticleId><ArticleId IdType="pubmed">19643506</ArticleId></ArticleIdList></Reference><Reference><Citation>Benito E, Barco A. The neuronal activity-driven transcriptome. Mol Neurobiol. 2015;51(3):1071&#x2013;1088. doi: 10.1007/s12035-014-8772-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8772-z</ArticleId><ArticleId IdType="pubmed">24935719</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;sing P, et al. SRF modulates seizure occurrence, activity induced gene transcription and hippocampal circuit reorganization in the mouse pilocarpine epilepsy model. Mol Brain. 2017;10(1):30. doi: 10.1186/s13041-017-0310-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0310-2</ArticleId><ArticleId IdType="pmc">PMC5513048</ArticleId><ArticleId IdType="pubmed">28716058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzniewska B, et al. Adult deletion of SRF increases epileptogenesis and decreases activity-induced gene expression. Mol Neurobiol. 2016;53(3):1478&#x2013;1493. doi: 10.1007/s12035-014-9089-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9089-7</ArticleId><ArticleId IdType="pmc">PMC4789231</ArticleId><ArticleId IdType="pubmed">25636686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulimood NS, et al. The role of CREB, SRF, and MEF2 in activity-dependent neuronal plasticity in the visual cortex. J Neurosci. 2017;37(28):6628&#x2013;6637. doi: 10.1523/JNEUROSCI.0766-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0766-17.2017</ArticleId><ArticleId IdType="pmc">PMC5508254</ArticleId><ArticleId IdType="pubmed">28607167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanan N, et al. SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability. Nat Neurosci. 2005;8(6):759&#x2013;767. doi: 10.1038/nn1462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1462</ArticleId><ArticleId IdType="pubmed">15880109</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkitna JR, et al. Loss of the serum response factor in the dopamine system leads to hyperactivity. FASEB J. 2010;24(7):2427&#x2013;2435. doi: 10.1096/fj.09-151423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-151423</ArticleId><ArticleId IdType="pubmed">20223941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimprich A, et al. Serum response factor (SRF) ablation interferes with acute stress-associated immediate and long-term coping mechanisms. Mol Neurobiol. 2017;54(10):8242&#x2013;8262. doi: 10.1007/s12035-016-0300-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0300-x</ArticleId><ArticleId IdType="pubmed">27914009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerosa L, et al. SRF and SRF&#x394;5 splicing isoform recruit corepressor LSD1/KDM1A modifying structural neuroplasticity and environmental stress response. Mol Neurobiol. 2020;57(1):393&#x2013;407. doi: 10.1007/s12035-019-01720-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01720-8</ArticleId><ArticleId IdType="pubmed">31364026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern S, et al. Serum response factor modulates neuron survival during peripheral axon injury. J Neuroinflammation. 2012;9:78. doi: 10.1186/1742-2094-9-78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-78</ArticleId><ArticleId IdType="pmc">PMC3404922</ArticleId><ArticleId IdType="pubmed">22537405</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern S, et al. The transcription factor serum response factor stimulates axon regeneration through cytoplasmic localization and cofilin interaction. J Neurosci. 2013;33(48):18836&#x2013;18848. doi: 10.1523/JNEUROSCI.3029-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3029-13.2013</ArticleId><ArticleId IdType="pmc">PMC6618710</ArticleId><ArticleId IdType="pubmed">24285890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieker C, et al. Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP-induced oxidative stress. Eur J Neurosci. 2012;35(5):735&#x2013;741. doi: 10.1111/j.1460-9568.2012.08003.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2012.08003.x</ArticleId><ArticleId IdType="pubmed">22356487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SH, et al. A novel role for serum response factor in neuronal survival. J Neurosci. 2004;24(9):2277&#x2013;2285. doi: 10.1523/JNEUROSCI.4868-03.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4868-03.2004</ArticleId><ArticleId IdType="pmc">PMC6730428</ArticleId><ArticleId IdType="pubmed">14999078</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rstner P, Kn&#xf6;ll B. Interference of neuronal activity-mediated gene expression through serum response factor deletion enhances mortality and hyperactivity after traumatic brain injury. FASEB J. 2020;34(3):3855&#x2013;3873. doi: 10.1096/fj.201902257RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902257RR</ArticleId><ArticleId IdType="pubmed">31930559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N, et al. NF-&#x3ba;B activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 2018;37(16):e98697. doi: 10.15252/embj.201798697.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, et al. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52(1):39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, et al. Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis. J Neuromuscul Dis. 2015;2(2):137&#x2013;150. doi: 10.3233/JND-140068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-140068</ArticleId><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, et al. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J Vis Exp. 2015;(104):53257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692639</ArticleId><ArticleId IdType="pubmed">26485052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick ND, et al. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc Natl Acad Sci U S A. 2017;114(39):E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese A, et al. Retinoic acid worsens ATG10-dependent autophagy impairment in TBK1-mutant hiPSC-derived motoneurons through SQSTM1/p62 accumulation. Autophagy. 2019;15(10):1719&#x2013;1737. doi: 10.1080/15548627.2019.1589257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1589257</ArticleId><ArticleId IdType="pmc">PMC6735587</ArticleId><ArticleId IdType="pubmed">30939964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, et al. Autophagy and ALS: mechanistic insights and therapeutic implications. Autophagy. 2022;18(2):254&#x2013;282. doi: 10.1080/15548627.2021.1926656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1926656</ArticleId><ArticleId IdType="pmc">PMC8942428</ArticleId><ArticleId IdType="pubmed">34057020</ArticleId></ArticleIdList></Reference><Reference><Citation>Schratt G, et al. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J Cell Biol. 2002;156(4):737&#x2013;750. doi: 10.1083/jcb.200106008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200106008</ArticleId><ArticleId IdType="pmc">PMC2174087</ArticleId><ArticleId IdType="pubmed">11839767</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, et al. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci. 2005;25(1):108&#x2013;117. doi: 10.1523/JNEUROSCI.4253-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4253-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725218</ArticleId><ArticleId IdType="pubmed">15634772</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogov VV, et al. Structural and functional analysis of the GABARAP interaction motif (GIM) EMBO Rep. 2017;18(8):1382&#x2013;1396. doi: 10.15252/embr.201643587.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201643587</ArticleId><ArticleId IdType="pmc">PMC5538626</ArticleId><ArticleId IdType="pubmed">28655748</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus CJ, et al. Chemical and genetic engineering of selective ion channel-ligand interactions. Science. 2011;333(6047):1292&#x2013;1296. doi: 10.1126/science.1206606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1206606</ArticleId><ArticleId IdType="pmc">PMC3210548</ArticleId><ArticleId IdType="pubmed">21885782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N, et al. Multiplexed chemogenetics in astrocytes and motoneurons restore blood-spinal cord barrier in ALS. Life Sci Alliance. 2020;3(11):e201900571. doi: 10.26508/lsa.201900571.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900571</ArticleId><ArticleId IdType="pmc">PMC7479971</ArticleId><ArticleId IdType="pubmed">32900826</ArticleId></ArticleIdList></Reference><Reference><Citation>Etkin A, et al. A role in learning for SRF: deletion in the adult forebrain disrupts LTD and the formation of an immediate memory of a novel context. Neuron. 2006;50(1):127&#x2013;143. doi: 10.1016/j.neuron.2006.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.03.013</ArticleId><ArticleId IdType="pubmed">16600861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell RD, et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol. 2009;11(2):143&#x2013;153. doi: 10.1038/ncb1819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1819</ArticleId><ArticleId IdType="pmc">PMC2654279</ArticleId><ArticleId IdType="pubmed">19098903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow N, et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer&#x2019;s phenotype. Proc Natl Acad Sci U S A. 2007;104(3):823&#x2013;828. doi: 10.1073/pnas.0608251104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0608251104</ArticleId><ArticleId IdType="pmc">PMC1783398</ArticleId><ArticleId IdType="pubmed">17215356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kn&#xf6;ll B, et al. Serum response factor controls neuronal circuit assembly in the hippocampus. Nat Neurosci. 2006;9(2):195&#x2013;204. doi: 10.1038/nn1627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1627</ArticleId><ArticleId IdType="pubmed">16415869</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CL, et al. SRF phosphorylation by glycogen synthase kinase-3 promotes axon growth in hippocampal neurons. J Neurosci. 2014;34(11):4027&#x2013;4042. doi: 10.1523/JNEUROSCI.4677-12.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4677-12.2014</ArticleId><ArticleId IdType="pmc">PMC6705271</ArticleId><ArticleId IdType="pubmed">24623780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu PP, Ramanan N. A critical cell-intrinsic role for serum response factor in glial specification in the CNS. J Neurosci. 2012;32(23):8012&#x2013;8023. doi: 10.1523/JNEUROSCI.5633-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5633-11.2012</ArticleId><ArticleId IdType="pmc">PMC6620932</ArticleId><ArticleId IdType="pubmed">22674276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickramasinghe SR, et al. Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. Neuron. 2008;58(4):532&#x2013;545. doi: 10.1016/j.neuron.2008.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.03.006</ArticleId><ArticleId IdType="pmc">PMC2689374</ArticleId><ArticleId IdType="pubmed">18498735</ArticleId></ArticleIdList></Reference><Reference><Citation>Seijffers R, et al. ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation. Proc Natl Acad Sci U S A. 2014;111(4):1622&#x2013;1627. doi: 10.1073/pnas.1314826111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314826111</ArticleId><ArticleId IdType="pmc">PMC3910594</ArticleId><ArticleId IdType="pubmed">24474789</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning CE, et al. Reward Network Immediate Early Gene Expression in Mood Disorders. Front Behav Neurosci. 2017;11:77. doi: 10.3389/fnbeh.2017.00077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2017.00077</ArticleId><ArticleId IdType="pmc">PMC5408019</ArticleId><ArticleId IdType="pubmed">28503137</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey K, et al. Autophagy coupled to translation is required for long-term memory. Autophagy. 2021;17(7):1614&#x2013;1635. doi: 10.1080/15548627.2020.1775393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1775393</ArticleId><ArticleId IdType="pmc">PMC8354608</ArticleId><ArticleId IdType="pubmed">32501746</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, et al. NPAS4 suppresses propofol-induced neurotoxicity by inhibiting autophagy in hippocampal neuronal cells. Arch Biochem Biophys. 2021;711:109018. doi: 10.1016/j.abb.2021.109018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2021.109018</ArticleId><ArticleId IdType="pubmed">34418347</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X-Y, et al. Serum response factor promotes dopaminergic neuron survival via activation of Beclin 1-dependent autophagy. Neuroscience. 2018;371:288&#x2013;295. doi: 10.1016/j.neuroscience.2017.11.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.11.040</ArticleId><ArticleId IdType="pubmed">29196028</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, et al. Regulation of SRF protein stability by an autophagy-dependent pathway. Biochem Biophys Res Commun. 2020;521(2):279&#x2013;284. doi: 10.1016/j.bbrc.2019.09.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.09.104</ArticleId><ArticleId IdType="pmc">PMC7043231</ArticleId><ArticleId IdType="pubmed">31668369</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A, et al. Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy. 2016;12(7):1094&#x2013;1104. doi: 10.1080/15548627.2016.1170257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1170257</ArticleId><ArticleId IdType="pmc">PMC4990988</ArticleId><ArticleId IdType="pubmed">27158844</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela V, et al. Unraveling the role of motoneuron autophagy in ALS. Autophagy. 2018;14(4):733&#x2013;737. doi: 10.1080/15548627.2018.1432327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1432327</ArticleId><ArticleId IdType="pmc">PMC5959335</ArticleId><ArticleId IdType="pubmed">29388464</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding O, et al. ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy. Proc Natl Acad Sci U S A. 2021;118(24):e2025053118. doi: 10.1073/pnas.2025053118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2025053118</ArticleId><ArticleId IdType="pmc">PMC8214690</ArticleId><ArticleId IdType="pubmed">34099552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamburg JR, et al. ADF/Cofilin-actin rods in neurodegenerative diseases. Curr Alzheimer Res. 2010;7(3):241&#x2013;250. doi: 10.2174/156720510791050902.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720510791050902</ArticleId><ArticleId IdType="pmc">PMC4458070</ArticleId><ArticleId IdType="pubmed">20088812</ArticleId></ArticleIdList></Reference><Reference><Citation>Munsie LN, et al. Cofilin nuclear-cytoplasmic shuttling affects cofilin-actin rod formation during stress. J Cell Sci. 2012;125(pt 17):3977&#x2013;3988.</Citation><ArticleIdList><ArticleId IdType="pubmed">22623727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes ZI, et al. Exciting complexity: the role of motor circuit elements in ALS pathophysiology. Front Neurosci. 2020;14:573. doi: 10.3389/fnins.2020.00573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00573</ArticleId><ArticleId IdType="pmc">PMC7311855</ArticleId><ArticleId IdType="pubmed">32625051</ArticleId></ArticleIdList></Reference><Reference><Citation>King AE, et al. Excitotoxicity in ALS: overstimulation, or overreaction? Exp Neurol. 2016;275 Pt 1:162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand J, et al. Hypoexcitability of motoneurons: an early pathological sign in ALS. Neuroscience. 2021;465:233&#x2013;234. doi: 10.1016/j.neuroscience.2021.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.03.015</ArticleId><ArticleId IdType="pubmed">34053506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5(208):208ra149. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen BK, et al. Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment. EMBO Mol Med. 2020;12(5):e10722. doi: 10.15252/emmm.201910722.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910722</ArticleId><ArticleId IdType="pmc">PMC7207170</ArticleId><ArticleId IdType="pubmed">32347002</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins EM, et al. Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction. Mol Neurodegener. 2021;16(1):13. doi: 10.1186/s13024-021-00433-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00433-8</ArticleId><ArticleId IdType="pmc">PMC7931347</ArticleId><ArticleId IdType="pubmed">33663561</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, et al. Neuronal migration in the murine rostral migratory stream requires serum response factor. Proc Natl Acad Sci U S A. 2005;102(17):6148&#x2013;6153. doi: 10.1073/pnas.0501191102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501191102</ArticleId><ArticleId IdType="pmc">PMC1087932</ArticleId><ArticleId IdType="pubmed">15837932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu Reckendorf SM, et al. Motoneuron-specific PTEN deletion in mice induces neuronal hypertrophy and also regeneration after facial nerve injury. J Neurosci. 2022;42(12):2474&#x2013;2491. doi: 10.1523/JNEUROSCI.1305-21.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1305-21.2022</ArticleId><ArticleId IdType="pmc">PMC8944241</ArticleId><ArticleId IdType="pubmed">35149515</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 2014;128(4):485&#x2013;503. doi: 10.1007/s00401-014-1329-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1329-4</ArticleId><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>